Genomic Medicine is a rapidly developing science-driven approach to health care. It potentially holds great benefits for patients, clinicians, heal
Lees meerAbstractThe type I collagenopathies are a group of heterogeneous connective tissue disorders, that are caused by mutations in the genes encoding type I collagen and include specific forms of osteogenesis imperfecta (OI) and the Ehlers-Danlos syndrome (EDS). These disorders present with a broad disease spectrum and large clinical variability of whi...
Lees meerBiallelic B3GALT6 mutations cause spondylodysplastic Ehlers-Danlos syndrome. Authors:Van Damme T, Pang X, Guillemyn B, Gulberti S, Syx D, De Rycke R, Kaye O,de Die-Smulders CEM, Pfundt R, Kariminejad A, Nampoothiri S, Pierquin G, Bulk S, Larson AA, Chatfield KC, Simon M, Legrand ...
Lees meerWhen: 26th - 29th of September 2018 Where: The Oude Vismijn, in the historic city center of Ghent Website: https://www.ehlers-danlos.com/2018-eds-ghent/ More Information: International Symposium EDS ...
Lees meerPhD fellowship vacancy in pediatric oncology "Therapy response monitoring in pediatric cancer basket trial patients" The position: The cancer research team at the Center for Medical Genetics (cmgg.be) (supervised by prof. dr. ir. Jo Vandesompele, prof. dr. Tom Van Maerke...
Lees meer